The Journal of Pharmaceutical Investigation announced a January 2027 special issue focused on translational advances in pharmaceutical dosage form development via particle engineering and formulation science. Edited by Korean pharmaceutical scientists, the call highlights manufacturing and solid-state/particle control as key bridges between lab prototypes and scalable medicines, with submissions due June 30, 2026.